StockWatch
·

Research Reports

09 Nov 2026
AMANTAAmanta Healthcare Ltd

Strong Quarter, Scaled-Back Outlook — The Real Number Is Lower

SteriPort · capacity-ramp · margin-resilience

Result verdictFollow-upQ2 FY276 minPharma & Healthcare
AMANTAAmanta Healthcare Ltd

Strong Q2 delivery, FY27 guidance cut; SteriPort ramp-up on track

SteriPort Line 3 · capacity ramp · margin resilience

TranscriptDeep diveQ2 FY276 minPharma & Healthcare
MOREPENLABMOREPEN LABORATORIES LTD.

Morepen launches its first US prescription generic, moving from API supplier toward finished-dose sales

Morepen Laboratories · US generics · Desloratadine

Research4 minPharma & Healthcare
PARKHOSPSPark Medi World Ltd

Execution on the expansion road — can Q2 sustain 19%+ growth?

healthcare · hospital expansion · revenue growth

Result previewQ2 FY273 minPharma & Healthcare
NATCOPHARMNATCO PHARMA LTD.

Can Natco stem the Revlimid cliff? Q2 revenue trajectory under watch

Revlimid decline · revenue stabilization · US generic launches

Result previewQ2 FY273 minPharma & Healthcare
JUBLPHARMAJubilant Pharmova Ltd

Radiopharma Scaling Into Margin Headwinds—Execution Risk on SPECT Recovery

CDMO · radiopharma · SPECT

Result previewQ2 FY273 minPharma & Healthcare
08 Nov 2026
ALKEMAlkem Laboratories Ltd

Alkem Labs: Domestic Momentum & Margin Reset After Q1 Tax Drag

pharma · domestic growth · US expansion

Result previewQ2 FY273 minPharma & Healthcare
MANIPALHOSManipal Health Enterprises Ltd

Growth delivering, margins under watch—what to expect from Manipal's first full quarter post-IPO

healthcare · hospital expansion · margin recovery

Result previewQ2 FY273 minPharma & Healthcare
07 Nov 2026
LAXMIDENTLLaxmi Dental Ltd

Strong margins, growth guidance miss

margin expansion · scanner transition · aligner scale

TranscriptDeep diveQ2 FY276 minPharma & Healthcare
KRSNAAKrsnaa Diagnostics Ltd

31% Revenue Growth, But Profit Growth Flatlines — and Here's Why It Matters

working-capital-crisis · margin-compression · rajasthan-ramp

Result verdictFollow-upQ2 FY276 minPharma & Healthcare
KRSNAAKrsnaa Diagnostics Ltd

31% revenue growth, but PAT flat; Rajasthan ramp-up absorbing margins

Rajasthan ramp-up · receivables spike · margin compression

TranscriptDeep diveQ2 FY276 minPharma & Healthcare
SHALBYShalby Ltd

9% growth masks hospital margin squeeze; Gurgaon breakout doesn't offset core pressure

hospital margin · Gurgaon growth · PAT collapse

Result verdictFollow-upQ2 FY276 minPharma & Healthcare
SHALBYShalby Ltd

9% growth masked by margin compression; Gurgaon bright spot offsets hospital headwinds

hospital expansion · Gurgaon scaling · margin pressure

TranscriptDeep diveQ2 FY276 minPharma & Healthcare
SAIPARENTSai Parenterals Ltd

Margins Inflect, but FY28 Story Trades at Execution Discount

margin expansion · capex inflection · Australia contracts

Result verdictFollow-upQ2 FY276 minPharma & Healthcare
SAIPARENTSai Parenterals Ltd

Margins inflect sharply; three new profit centers loading for FY28

gross margin expansion · EBITDA guidance maintained · capacity expansion on track

TranscriptDeep diveQ2 FY276 minPharma & Healthcare
HESTERBIOHESTER BIOSCIENCES LTD.

Revenue Growth Masks a Profit Collapse That Management Won't Explain

biologicals pipeline · Africa expansion · profit collapse

Result verdictFollow-upQ2 FY276 minPharma & Healthcare
HESTERBIOHESTER BIOSCIENCES LTD.

Strong YoY growth masks QoQ PAT collapse; Africa expansion bullish but unquantified

biologicals pipeline · Africa expansion · regulatory tightening

TranscriptDeep diveQ2 FY276 minPharma & Healthcare
ZYDUSLIFEZydus Lifesciences Ltd

Revenue surges 29%, profit sinks 25%—the Saro investment revealed

revenue growth · profit decline · Saro investment

Result verdictFollow-upQ2 FY276 minPharma & Healthcare
ZYDUSLIFEZydus Lifesciences Ltd

Growth masks profit decline; Saro investment ahead

revenue momentum · margin pressure · Saro launch

TranscriptDeep diveQ2 FY276 minPharma & Healthcare
NHNarayana Hrudayalaya Ltd

Record Revenue Growth, Profit Letdown: The 56pp Divergence

earnings quality · international losses · insurance drag

Result verdictFollow-upQ2 FY276 minPharma & Healthcare
NHNarayana Hrudayalaya Ltd

Strong India growth, but international losses drag earnings quality

India margin · insurance losses · UK integration

TranscriptDeep diveQ2 FY276 minPharma & Healthcare
DIVISLABDIVI'S LABORATORIES LTD.

Divi's Labs consolidated PAT surges 64% YoY to ₹1,127 Cr, margins hit record 42.6%

pharma api · custom synthesis · margin expansion

ResultsQ2 FY273 minPharma & Healthcare
CAPLIPOINTCAPLIN POINT LABORATORIES LTD.

Margin expansion on solid growth — can Q2 sustain Q1's momentum?

caplin point · q2 fy27 · pharma growth

Result previewQ2 FY273 minPharma & Healthcare
06 Nov 2026
IPCALABIPCA LABORATORIES LTD.

Revenue on Track, But Margins Compressed—Pricing Power Gets Tested

margin compression · pricing power · freight headwinds

Result verdictFollow-upQ2 FY276 minPharma & Healthcare
IPCALABIPCA LABORATORIES LTD.

14% revenue growth on track; PAT down QoQ amid cost pressures

domestic formulation 14% · export 32% · generics 36%

TranscriptDeep diveQ2 FY276 minPharma & Healthcare
NEULANDLABNEULAND LABORATORIES LTD.

Long-Term Bets, Near-Term Miss — Credibility on the Line

CDMO · margin compression · customer concentration

Result verdictFollow-upQ2 FY276 minPharma & Healthcare
NEULANDLABNEULAND LABORATORIES LTD.

Revenue -12.6% YoY, PAT -46.7%; long-term bets positioned but near-term opaque

peptides_commercialization · customer_concentration · margin_compression

TranscriptDeep diveQ2 FY276 minPharma & Healthcare
ASTERDMAster DM Healthcare Ltd

Aster DM Quality Care: PAT ₹322 Cr as QCIL merger jumps scale; margins recover YoY

hospitals · merger integration · quality care amalgamation

ResultsQ2 FY273 minPharma & Healthcare
EMCUREEmcure Pharmaceuticals Ltd

24% growth & guidance raised — but the stock is priced for perfection at overbought levels

guidance raise · international growth · EBITDA expansion

Result verdictFollow-upQ2 FY276 minPharma & Healthcare
EMCUREEmcure Pharmaceuticals Ltd

Guidance raised to >20% growth; Q2 delivers 24% YoY, margin expands 100 bps

revenue growth acceleration · EBITDA margin expansion · international momentum

TranscriptDeep diveQ2 FY276 minPharma & Healthcare